Sree Rayalaseema Hi-Strength Hypo Ltd
Incorporated in 2005, Sree Rayalaseema
Hi – Strength Hypo Ltd is a producer of
producer of Calcium Hypo -chloride,
Stable Bleaching Powder, Sulphuric
Acid and other chemicals[1]
- Market Cap ₹ 1,316 Cr.
- Current Price ₹ 767
- High / Low ₹ 795 / 439
- Stock P/E 15.6
- Book Value ₹ 467
- Dividend Yield 0.39 %
- ROCE 15.7 %
- ROE 11.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 4.28% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
299 | 295 | 392 | 362 | 366 | 546 | 702 | 689 | 911 | 1,267 | 1,650 | 866 | 774 | |
258 | 262 | 351 | 318 | 317 | 500 | 604 | 587 | 781 | 1,119 | 1,470 | 755 | 672 | |
Operating Profit | 41 | 33 | 41 | 44 | 50 | 46 | 98 | 102 | 130 | 149 | 180 | 111 | 102 |
OPM % | 14% | 11% | 10% | 12% | 14% | 8% | 14% | 15% | 14% | 12% | 11% | 13% | 13% |
-4 | 9 | 9 | 2 | -2 | 19 | 5 | 4 | 7 | 11 | 34 | 13 | 15 | |
Interest | 10 | 16 | 14 | 11 | 8 | 9 | 16 | 10 | 5 | 3 | 5 | 4 | 4 |
Depreciation | 13 | 15 | 10 | 10 | 25 | 19 | 45 | 50 | 51 | 19 | 19 | 11 | 9 |
Profit before tax | 13 | 12 | 26 | 26 | 15 | 37 | 42 | 45 | 81 | 137 | 190 | 109 | 104 |
Tax % | 27% | 36% | 25% | 27% | -27% | 1% | 52% | 17% | 25% | 25% | 19% | 26% | |
9 | 7 | 19 | 19 | 18 | 37 | 20 | 38 | 61 | 103 | 154 | 80 | 77 | |
EPS in Rs | 6.53 | 5.06 | 13.16 | 12.72 | 11.86 | 22.45 | 11.90 | 22.09 | 35.30 | 59.88 | 89.90 | 46.85 | 44.63 |
Dividend Payout % | 0% | 0% | 11% | 12% | 13% | 9% | 17% | 11% | 8% | 6% | 4% | 6% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 4% |
3 Years: | -2% |
TTM: | -42% |
Compounded Profit Growth | |
---|---|
10 Years: | 28% |
5 Years: | 36% |
3 Years: | 13% |
TTM: | -41% |
Stock Price CAGR | |
---|---|
10 Years: | 29% |
5 Years: | 50% |
3 Years: | 27% |
1 Year: | 28% |
Return on Equity | |
---|---|
10 Years: | 14% |
5 Years: | 17% |
3 Years: | 17% |
Last Year: | 11% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 14 | 15 | 15 | 15 | 15 | 16 | 17 | 17 | 17 | 17 | 17 | 17 |
Reserves | 125 | 135 | 157 | 173 | 222 | 300 | 308 | 294 | 371 | 553 | 734 | 785 |
117 | 88 | 87 | 85 | 55 | 78 | 52 | 57 | 72 | 28 | 16 | 5 | |
102 | 130 | 99 | 84 | 60 | 66 | 93 | 76 | 59 | 189 | 174 | 100 | |
Total Liabilities | 358 | 367 | 358 | 357 | 352 | 460 | 470 | 445 | 519 | 787 | 941 | 907 |
155 | 200 | 194 | 195 | 182 | 194 | 194 | 161 | 134 | 130 | 105 | 103 | |
CWIP | 52 | 0 | 5 | 2 | 8 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
Investments | 31 | 32 | 23 | 23 | 43 | 105 | 65 | 18 | 50 | 164 | 268 | 253 |
120 | 135 | 136 | 137 | 118 | 161 | 210 | 262 | 334 | 494 | 568 | 551 | |
Total Assets | 358 | 367 | 358 | 357 | 352 | 460 | 470 | 445 | 519 | 787 | 941 | 907 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
47 | 20 | 36 | 15 | 47 | 5 | 60 | 99 | 71 | 60 | 131 | 132 | |
-68 | -9 | -5 | -3 | -19 | -27 | -24 | -38 | -115 | -1 | -99 | -8 | |
21 | -9 | -32 | -12 | -19 | 16 | -37 | -22 | 10 | -52 | -20 | -22 | |
Net Cash Flow | -0 | 2 | -1 | -0 | 8 | -6 | -1 | 40 | -35 | 7 | 12 | 103 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 35 | 33 | 33 | 54 | 30 | 38 | 46 | 43 | 39 | 38 | 33 | 45 |
Inventory Days | 50 | 67 | 42 | 37 | 55 | 34 | 34 | 36 | 27 | 62 | 39 | 24 |
Days Payable | 86 | 97 | 79 | 39 | 66 | 21 | 38 | 24 | 8 | 33 | 22 | 10 |
Cash Conversion Cycle | -0 | 3 | -4 | 51 | 19 | 51 | 41 | 55 | 57 | 67 | 50 | 59 |
Working Capital Days | 23 | 15 | 12 | 48 | 42 | 48 | 52 | 46 | 48 | 53 | 47 | 67 |
ROCE % | 13% | 11% | 13% | 14% | 9% | 9% | 14% | 15% | 21% | 26% | 26% | 16% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 26 Sep
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 25 Sep
- Closure of Trading Window 24 Sep
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 24 Sep
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 23 Sep
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Segments